Life Sciences
Market Access/ Views & Analysis/ Views and analysis
Global comparator data signal “alarm bells” for UK Government, says APBI
Amanda Barrell
ABPI, clinical trial recruitment, clinical trials, Life Sciences, UK life sciences, UK market access
0 Comment
News/ News/ News/ News/ Patients/ R&D/ Sales and Marketing
Report finds UK risks falling behind rivals in life sciences
Phil Taylor
ABPI, BIA, clinical trials, competition, financing, Life Sciences, UK
0 Comment
Patients/ R&D/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis
The post-Covid New Normal: a golden opportunity for the NHS?
Paul Tunnah
Innovation, Life Sciences, NHS, NHSE, Ping Conference
0 Comment
Partners come on board GSK’s plan for Stevenage life science hub
Phil Taylor
cluster, GlaxoSmithKline, Life Sciences, UK
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis
Spotlight on Women in Science: Giulia Guerrini
Eloise McLennan
giulia guerrini, Life Sciences, Medino, STEM, women in science
0 Comment
Genomics England will move HQ to Canary Wharf’s new biocluster
Phil Taylor
Biotech, cluster, Genomics England, Life Sciences, UK
0 Comment
GSK said to be close to finding partner for science cluster in UK
Phil Taylor
cluster, GlaxoSmithKline, investment, Life Sciences, UK
0 Comment
PING Conference 2022 – The Golden Age for Life Sciences Innovation
ssaib@vwv.co.uk
Biotech, Innovation, Life Sciences, pharma, Pharmaceuticals
0 Comment
The Golden Age for Life Sciences Innovation